Clinical Data Initiates Phase III Trial for Cardiac Stress Testing

Clinical Data, Inc. announced that it has enrolled the first patient in its initial Phase III trial of Stedivazea, a potential best-in-class vasodilator for use in cardiac stress testing.
Genetic Engineering & Biotechnology News